PMID- 38164252 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20240103 IS - 2296-2646 (Print) IS - 2296-2646 (Electronic) IS - 2296-2646 (Linking) VI - 11 DP - 2023 TI - Evaluation of the in vitro antioxidant and antitumor activity of hydroalcoholic extract from Jatropha mollissima leaves in Wistar rats. PG - 1283618 LID - 10.3389/fchem.2023.1283618 [doi] LID - 1283618 AB - Introduction: Despite modern sciences and advancements in new drugs or chemicals, the new era now rushes natural remedies for various illnesses and diseases that lead to end organ damage. In this study, we investigated Jatropha mollissima ethanolic extract's effect against doxorubicin-induced cardiotoxicity and renal toxicity. Methods: To determine phytochemicals, a phytochemical screening was conducted. Various assays were used to measure the antioxidant activity, including the DPPH (2,2-diphenylpicrylhydrazyl), SOD (superoxide dismutase), NO (nitric oxide), and others. The antiproliferative effect of Jm was assessed by MTT assay; morphological analysis was performed using an inverted and phase contrast microscope, ultra morphological analysis of apoptosis with acridine orange (AO)/propidium iodide (PI) staining. Results: It was seen that doxorubicin caused elevated serum markers and abnormal changes in histological patterns. The significant reduction in cardiac and renal marker levels seen in groups given either 400 or 600 mg/kg of crude extract demonstrates that Jm has a protective effect against doxorubicin-induced cardiotoxicity due to the presence of active phytoconstituents having antioxidant potential. There is a dose-dependent decrease in cell viability when using J. mollissima. Apoptosis was observed in the treated cells. Conclusion: In conclusion, our research lends credence to the idea that J. mollissima could be used for cancer management and have cardioprotective and nephroprotective effects. CI - Copyright (c) 2023 Iqbal, Gu, Khan, Wang and Chen. FAU - Iqbal, Muhammad Omer AU - Iqbal MO AD - College of Marine Science and Biological Engineering, Qingdao University of Science and Technology, Qingdao, China. AD - Key Laboratory of Marine Drugs, The Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao, China. AD - Fatima Tu Zahara Department of Life Sciences, Muhammad Institute of Medical and Allied Sciences, Multan, Pakistan. FAU - Gu, Yuchao AU - Gu Y AD - College of Marine Science and Biological Engineering, Qingdao University of Science and Technology, Qingdao, China. FAU - Khan, Imran Ahmad AU - Khan IA AD - Fatima Tu Zahara Department of Life Sciences, Muhammad Institute of Medical and Allied Sciences, Multan, Pakistan. AD - Department of Pharmacy, MNS University of Agriculture, Multan, Pakistan. FAU - Wang, Ruihong AU - Wang R AD - The Affiliated Qingdao Central Hospital of Qingdao University, Qingdao, China. FAU - Chen, Jin AU - Chen J AD - College of Marine Science and Biological Engineering, Qingdao University of Science and Technology, Qingdao, China. LA - eng PT - Journal Article DEP - 20231218 PL - Switzerland TA - Front Chem JT - Frontiers in chemistry JID - 101627988 PMC - PMC10757942 OTO - NOTNLM OT - Jatropha mollissima OT - anticancer OT - antioxidant OT - cardioprotective OT - doxorubicin OT - nephroprotective COIS- The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. EDAT- 2024/01/02 11:44 MHDA- 2024/01/02 11:45 PMCR- 2023/01/01 CRDT- 2024/01/02 03:39 PHST- 2023/08/26 00:00 [received] PHST- 2023/12/04 00:00 [accepted] PHST- 2024/01/02 11:45 [medline] PHST- 2024/01/02 11:44 [pubmed] PHST- 2024/01/02 03:39 [entrez] PHST- 2023/01/01 00:00 [pmc-release] AID - 1283618 [pii] AID - 10.3389/fchem.2023.1283618 [doi] PST - epublish SO - Front Chem. 2023 Dec 18;11:1283618. doi: 10.3389/fchem.2023.1283618. eCollection 2023.